The inhibition of TLR4-NOX4 signalling significantly reduces the infarct volume after cerebral infarction and reperfusion and improves neurological functional scores, demonstrating that TLR4 represents a possible therapeutic target for CCI (Suzuki et al. 2012). Here, TLR4 is linked to brain infarction.